James J. Manfredi
Affiliations: | Cancer Biology | Icahn School of Medicine at Mount Sinai, New York, NY, United States |
Area:
Oncology, Biochemistry, Molecular Biology, Cell BiologyGoogle:
"James Manfredi"Mean distance: (not calculated yet)
Children
Sign in to add traineeEdward C. Thornborrow | grad student | 2001 | Mount Sinai School of Medicine |
Selvon St. Clair | grad student | 2002 | Mount Sinai School of Medicine |
Luciana E. Giono | grad student | 2006 | Mount Sinai School of Medicine |
Dana J. Lukin | grad student | 2006 | Mount Sinai School of Medicine |
Luis A. Carvajal | grad student | 2012 | Mount Sinai |
Crystal A. Tonnessen | grad student | 2013 | Mount Sinai School of Medicine |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Efe G, Dunbar KJ, Sugiura K, et al. (2023) p53 gain-of-function mutation induces metastasis via Brd4-dependent Csf-1 expression. Cancer Discovery |
Su Z, Kon N, Yi J, et al. (2023) Specific regulation of BACH1 by the hotspot mutant p53 reveals a distinct gain-of-function mechanism. Nature Cancer |
Resnick-Silverman L, Zhou R, Campbell MJ, et al. (2023) In vivo RNA-seq and ChIP-seq analyses show an obligatory role for the C terminus of p53 in conferring tissue-specific radiation sensitivity. Cell Reports. 42: 112216 |
Tong DR, Zhou W, Katz C, et al. (2021) p53 frameshift mutations couple loss-of-function with unique neomorphic activities. Molecular Cancer Research : McR |
Manfredi JJ. (2021) Mdm2 and MdmX: Partners in p53 Destruction. Cancer Research. 81: 1633-1634 |
Farkas M, Hashimoto H, Bi Y, et al. (2021) Distinct mechanisms control genome recognition by p53 at its target genes linked to different cell fates. Nature Communications. 12: 484 |
Kon N, Churchill M, Li H, et al. (2020) Robust p53 stabilization is dispensable for its activation and tumor suppressor function. Cancer Research |
Manfredi JJ. (2019) p53 defies convention again: a p53 mutant that has lost tumor suppression but still can kill. The Embo Journal. e103322 |
Manfredi JJ. (2019) Inactivation of Wild-Type p53 by Asparagine Endopeptidase in Glioblastoma: An Opportunity to Target the "Undruggable". Journal of the National Cancer Institute |
Manfredi JJ. (2019) p53 and Development: Shedding Light on an Evolutionary Enigma. Developmental Cell. 50: 128-129 |